IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

PEVERELLI, ERIKA MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.415
EU - Europa 5.281
AS - Asia 4.868
Continente sconosciuto - Info sul continente non disponibili 570
SA - Sud America 437
AF - Africa 132
OC - Oceania 14
Totale 17.717
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.145
CN - Cina 1.509
SG - Singapore 1.355
GB - Regno Unito 1.277
DE - Germania 1.185
IT - Italia 1.111
BD - Bangladesh 607
SE - Svezia 460
HK - Hong Kong 406
VN - Vietnam 355
RU - Federazione Russa 316
BR - Brasile 298
FR - Francia 203
CA - Canada 190
IN - India 190
NL - Olanda 169
FI - Finlandia 102
UA - Ucraina 99
IE - Irlanda 85
TR - Turchia 84
JP - Giappone 76
KR - Corea 76
CI - Costa d'Avorio 70
ID - Indonesia 67
DK - Danimarca 51
ES - Italia 49
AR - Argentina 46
MX - Messico 35
CO - Colombia 30
BE - Belgio 27
EU - Europa 26
PL - Polonia 25
RO - Romania 20
AT - Austria 19
ZA - Sudafrica 19
EC - Ecuador 18
CH - Svizzera 15
IQ - Iraq 13
GR - Grecia 12
PK - Pakistan 12
TW - Taiwan 12
CL - Cile 11
SK - Slovacchia (Repubblica Slovacca) 11
MY - Malesia 10
SA - Arabia Saudita 10
AE - Emirati Arabi Uniti 9
AU - Australia 9
EG - Egitto 9
IL - Israele 9
VE - Venezuela 9
BO - Bolivia 8
JM - Giamaica 8
HN - Honduras 7
NP - Nepal 7
PH - Filippine 7
SC - Seychelles 7
CR - Costa Rica 6
JO - Giordania 6
PE - Perù 6
PT - Portogallo 6
PY - Paraguay 6
TH - Thailandia 6
IR - Iran 5
LT - Lituania 5
NE - Niger 5
NZ - Nuova Zelanda 5
SV - El Salvador 5
TN - Tunisia 5
UZ - Uzbekistan 5
BY - Bielorussia 4
CZ - Repubblica Ceca 4
KE - Kenya 4
KG - Kirghizistan 4
LB - Libano 4
MA - Marocco 4
RS - Serbia 4
AZ - Azerbaigian 3
GT - Guatemala 3
GY - Guiana 3
HR - Croazia 3
KZ - Kazakistan 3
LU - Lussemburgo 3
NO - Norvegia 3
OM - Oman 3
PA - Panama 3
SI - Slovenia 3
DO - Repubblica Dominicana 2
GE - Georgia 2
LK - Sri Lanka 2
LV - Lettonia 2
MD - Moldavia 2
MK - Macedonia 2
MM - Myanmar 2
PS - Palestinian Territory 2
TT - Trinidad e Tobago 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AM - Armenia 1
AO - Angola 1
AW - Aruba 1
Totale 17.147
Salva come PNG Salva come JPEG
Città #
Dallas 1.294
Southend 1.141
Singapore 771
Hanover 677
Ashburn 667
Chandler 427
Hong Kong 359
Milan 352
San Jose 337
Santa Clara 278
Beijing 265
Council Bluffs 196
Ann Arbor 173
Seattle 161
Frankfurt am Main 152
Los Angeles 151
New York 146
Houston 140
Wilmington 122
Ho Chi Minh City 118
Fairfield 115
Princeton 114
Hefei 107
Buffalo 98
Dearborn 91
Dublin 83
Lauterbourg 80
Hanoi 78
Bengaluru 76
Woodbridge 76
Toronto 74
Abidjan 70
Rome 69
Munich 67
Nanjing 66
Jacksonville 62
Moscow 54
Jinan 50
Redwood City 47
Hangzhou 46
Tokyo 46
Shanghai 45
Helsinki 43
Boardman 41
Guangzhou 41
São Paulo 39
Columbus 38
Des Moines 38
Jakarta 38
The Dalles 33
Cambridge 32
Redmond 32
Serra 32
Grafing 31
Montreal 31
Naples 31
Chicago 28
Seoul 28
Berlin 27
Shenyang 26
Turin 26
Zhengzhou 26
Cangzhou 25
Mountain View 25
Phoenix 24
Tianjin 23
Amsterdam 21
Brussels 21
Nuremberg 21
Sunnyvale 21
Istanbul 20
Somerville 20
Bogotá 19
Padova 18
Sakarya 18
Andover 17
Changsha 17
Nanchang 17
Hebei 16
Da Nang 15
Jiaxing 15
London 15
Orem 15
Fremont 14
Johannesburg 14
San Diego 14
Shenzhen 14
Haiphong 13
Mumbai 13
Atlanta 12
Brooklyn 12
Palermo 11
Philadelphia 11
Washington 11
Wuhan 11
Athens 10
Bologna 10
Cinisello Balsamo 10
Florence 10
Hải Dương 10
Totale 10.805
Salva come PNG Salva come JPEG
Nome #
Pseudohypoparathyroidism and GNAS epigenetic defects : clinical evaluation of Albright hereditary osteodystrophy and molecular analysis in 40 patients 682
AZD1775: effect of monotherapy or EDP-M combination in the treatment of ACC preclinical models 463
Cofilin is a cAMP effector in mediating actin cytoskeleton reorganization and steroidogenesis in mouse and human adrenocortical tumor cells 460
Genetic profiling of a cohort of Italian patients with ACTH-secreting pituitary tumors and characterization of a novel USP8 gene variant 456
Sphingosine kinase 1 inhibitor safingol as a new possible therapeutic strategy for adrenocortical carcinoma 445
β-arrestin 2 is required for dopamine receptor type 2 inhibitory effects on AKT phosphorylation and cell proliferation in pituitary tumors 443
Cytoskeleton actin-binding proteins in clinical behavior of pituitary tumors 427
Octreotide and pasireotide effects on medullary thyroid carcinoma (MTC) cells growth, migration and invasion 395
The cytoskeleton actin binding protein filamin A impairs both IGF2 mitogenic effects and the efficacy of IGF1R inhibitors in adrenocortical cancer cells 393
A novel mechanism regulating dopamine receptor type 2 (DRD2) signal transduction in pituitary tumoral cells: the role of cAMP/PKA-induced filamin A (FLNA) phosphorylation 391
IGF2R: a new player in the insulin-like growth factor 2 (IGF2) pathway sustaining adrenocortical carcinoma cells growth 336
Proliferation of transformed somatotroph cells related to low or absent expression of protein kinase a regulatory subunit 1A protein 322
Analysis of genetic variants of phosphodiesterase 11A (PDE11A) in acromegalic patients 311
The third intracellular loop of the human somatostatin receptor 5 is crucial for arrestin binding and receptor internalization after somatostatin stimulation 295
Dopamine and somatostatin analogues resistance of pituitary tumors : focus on cytoskeleton involvement 289
Peripheral insulin-like factor 3 concentrations are reduced in men with type 2 diabetes mellitus : effect of glycemic control and visceral adiposity on Leydig cell function 288
PKA regulatory subunit R2B is required for murine and human adipocyte differentiation 286
Somatostatin analogs regulate tumor corticotrophs growth by reducing ERK1/2 activity. 281
Specific roles of Gi protein family members revealed by dissecting SST5 coupling in human pituitary cells 269
Expression of the two alternatively spliced PRKAR1A RNAs in human endocrine glands 265
DRD2 Agonist Cabergoline Abolished the Escape Mechanism Induced by mTOR Inhibitor Everolimus in Tumoral Pituitary Cells 264
cAMP/PKA-induced filamin A (FLNA) phosphorylation inhibits SST2 signal transduction in GH-secreting pituitary tumor cells 262
Dopamine receptor type 2 (DRD2) inhibits migration and invasion of human tumorous pituitary cells through ROCK-mediated cofilin inactivation 257
A novel pathway activated by somatostatin receptor type 2 (SST2): Inhibition of pituitary tumor cell migration and invasion through cytoskeleton protein recruitment 257
Effect of cyclic adenosine 3',5'-monophosphate/protein kinase a pathway on markers of cell proliferation in nonfunctioning pituitary adenomas 247
Octreotide promotes apoptosis in human somatotroph tumor cells by activating somatostatin receptor type 2 247
The third intracellular loop of the human somatostatin receptor 5 is crucial for arrestin binding and receptor internalisation after somatostatin stimulation 247
Analysis of GNAS1 and PRKAR1A gene mutations in human cardiac myxomas not associated with multiple endocrine disorders 240
Cofilin is a mediator of RET-promoted medullary thyroid carcinoma cell migration, invasion and proliferation. 233
Quantitative analysis of methylation defects and correlation with clinical characteristics in patients with pseudohypoparathyroidism type I and GNAS epigenetic alterations 233
Evaluation of proopiomelanocortin mRNA in the peripheral blood from patients with Cushing's syndrome of different origin 220
High expression of PKA regulatory subunit 1A protein is related to proliferation of human melanoma cells 220
Cytoskeleton protein Filamin A is required for efficient Somatostatin receptor type 2 internalization and recycling through Rab5 and Rab4 sorting endosomes in tumor somatotroph cells 220
Different expression of protein kinase A (PKA) regulatory subunits in cortisol-secreting adrenocortical tumors: Relationship with cell proliferation 217
Dopamine receptor type 2 (DRD2) and somatostatin receptor type 2 (SSTR2) agonists are effective in inhibiting proliferation of progenitor/stem-like cells isolated from nonfunctioning pituitary tumors 216
Filamin A (FLNA) Plays an essential role in somatostatin receptor 2 (SST2) signaling and stabilization after agonist stimulation in human and rat somatotroph tumor cells 214
Cyclic adenosine 3'-5'-monophosphate (cAMP) exerts proliferative and anti-proliferative effects in pituitary cells of different types by activating both cAMP-dependent protein kinase A (PKA) and exchange proteins directly activated by cAMP (Epac) 214
Single-Molecule Microscopy Reveals Dynamic FLNA Interactions Governing SSTR2 Clustering and Internalization 208
Stem Cells in Pituitary Tumors: Experimental Evidence Supporting Their Existence and Their Role in Tumor Clinical Behavior 196
The Novel SSTR3 Agonist ITF2984 Exerts Antimitotic and Proapoptotic Effects in Human Non-Functioning Pituitary Neuroendocrine Tumor (NF-PitNET) Cells 194
Drug resistance in pituitary tumours: from cell membrane to intracellular signalling 194
The dopamine-somatostatin chimeric compound BIM-23A760 exerts antiproliferative and cytotoxic effects in human non-functioning pituitary tumors by activating ERK1/2 and p38 pathways 193
Therapeutic potential of targeting the FLNA‐regulated Wee1 kinase in adrenocortical carcinomas 191
P720R USP8 Mutation Is Associated with a Better Responsiveness to Pasireotide in ACTH-Secreting PitNETs 189
Macroautophagy and the proteasome are differently involved in the degradation of alpha-synuclein wild type and mutated A30P in an in vitro inducible model (PC12/TetOn) 186
High Filamin a Expression in Adrenocortical Carcinomas Is Associated with a Favourable Tumour Behaviour: A European Multicentric Study 179
Filamin A in somatostatin and dopamine receptor regulation in pituitary and the role of cAMP/PKA dependent phosphorylation 179
cAMP effects in neuroendocrine tumors : the role of Epac and PKA in cell proliferation and adhesion 176
Expression of protein kinase A regulatory subunits in benign and malignant human thyroid tissues : a systematic review 173
Protective effect of TAT-delivered alpha-synuclein: relevance of the C-terminal domain and involvement of HSP70 173
A β-Arrestin 2-Biased Dopamine Receptor Type 2 (DRD2) Agonist Is More Efficacious Than Cabergoline in Reducing Cell Proliferation in PRL-Secreting but Not in Non-Functioning Pituitary Tumor Cells 172
TMPRSS2 Expression and Activity Modulation by Sex-Related Hormones in Lung Calu-3 Cells: Impact on Gender-Specific SARS-CoV-2 Infection 172
Autosomal Dominant Pseudohypoparathyroidism type Ib : a novel inherited deletion ablating STX16 causes Loss of Imprinting at the A/B DMR 172
Emerging role of IGF1R and IR expression and localisation in adrenocortical carcinomas 171
Somatostatin Receptor Type 2 (SSTR2) Internalization and Intracellular Trafficking in Pituitary GH-Secreting Adenomas: Role of Scaffold Proteins and Implications for Pharmacological Resistance 167
Filamin-a is required to mediate SST2 effects in pancreatic neuroendocrine tumours 157
Evolution of an aggressive prolactinoma into a growth hormone secreting pituitary tumor coincident with GNAS gene mutation 156
Dimerization of GPCRs: Novel insight into the role of FLNA and SSAs regulating SST2 and SST5 homo- and hetero-dimer formation 154
Identification of human somatostatin receptor 2 domains involved in internalization and signaling in QGP-1 pancreatic neuroendocrine tumor cell line 152
Filamin-A is essential for dopamine d2 receptor expression and signaling in tumorous lactotrophs 149
Characterization of intracellular signaling mediated by human somatostatin receptor 5 : role of the DRY motif and the third intracellular loop 143
HESX1 expression in human normal pituitaries and pituitary adenomas 141
Preclinical evaluation of the antitumoral efficacy of Wee1 inhibitor AZD1775 in adrenocortical carcinoma 139
Somatostatin analogues increase AIP expression in somatotropinomas, irrespective of Gsp mutations 134
Deciphering the specific role of G(αi/o) isoforms: functional selective oxytocin ligands and somatostatin SST5 receptor mutants 133
Therapeutic potential of targeting the FLNA-regulated Wee1 kinase in adrenocortical carcinomas 132
Pituitary tumors: genetic and molecular factors underlying pathogenesis and clinical behavior 128
Landscape of somatic mutations in sporadic GH-secreting pituitary adenomas 123
SCARB1 downregulation in adrenal insufficiency with Allgrove syndrome 120
cAMP in the pituitary : an old messenger for multiple signals 120
The novel SST3 agonist ITF2984 exerts antimitotic and proapoptotic effects in human non-functioning pituitary neuroendocrine tumor (NF-PitNET) cells 111
Role of filamin A in the pathogenesis of neuroendocrine tumors and adrenal cancer 106
Filamin A is required for somatostatin receptor type 5 expression and pasireotide-mediated signaling in pituitary corticotroph tumor cells 104
Potential antitumoral effects through modulation of VEGF-A splicing in rat somatotroph and lactotroph pituitary tumoral cells 99
USP8 inhibitor RA-9 reduces ACTH release and cell growth in tumor corticotrophs 93
Potential antitumoral effects of SRPK1 inhibition through modulation of VEGF splicing in pituitary somatotroph tumoral cells 91
Clinical predictors of outcome in advanced adrenocortical carcinoma: a multicenter international ENSAT study 80
The Cytoskeleton in Adrenal Physiology and Tumours: Functional Roles and Emerging Molecular Targets 78
miR-375 Regulation of SSTR2 Expression in Corticotroph Pituitary Cells: Somatostatin Receptor Ligands Effects 43
IGF2R: a new player in the IGF2 loop sustaining adrenocortical carcinogenesis 18
Biological targets and therapeutic strategies in the treatment of non-functioning pituitary tumors: state-of-the-art 13
Micromegaly: a distinct clinical entity? Insights from a monocentric cohort study 5
null 4
Pan-CDK and PLK1 inhibitors as a novel approach for targeted treatment of adrenocortical carcinomas 1
Totale 17.717
Salva come PNG Salva come JPEG
Categoria #
all - tutte 44.107
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.107
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.447 0 39 83 148 178 161 164 127 188 109 46 204
2022/20231.162 138 133 92 133 129 201 22 84 114 14 53 49
2023/2024873 37 50 35 58 269 22 85 81 23 60 69 84
2024/20252.183 73 114 30 225 224 123 55 215 126 262 227 509
2025/20266.983 555 1.471 576 480 469 295 662 219 587 418 730 521
2026/2027768 394 374 0 0 0 0 0 0 0 0 0 0
Totale 17.717